Findings

What do systematic reviews say?

3 questions · 4 findings · 1 reviews

No studies found 0 · 0%GRADE not reported 0 · 0%Very low 2 · 50%Low 1 · 25%Moderate 1 · 25%High 0 · 0%

Microbiological efficacy ‐ pathogen eradication · patients with chronic bacterial prostatitis

It is very uncertain whether levofloxacin changes microbiological efficacy ‐ pathogen eradication compared with ciprofloxacin (very low certainty).

1 finding from 1 review

Antimicrobial therapy for chronic bacterial prostatitis 2013 · Cochrane Headline outcomes only
RR 1.18 [0.81, 1.71]
2 studies · 669 participants
Very low

Clinical efficacy ‐ cure or improvement at · patients with chronic bacterial prostatitis

Levofloxacin showed no clear difference in clinical efficacy ‐ cure or improvement at end of treatment compared with ciprofloxacin (low certainty).

2 findings from 1 review

Antimicrobial therapy for chronic bacterial prostatitis 2013 · Cochrane Headline outcomes only
RR 1.16 [0.93, 1.46]
2 studies · 669 participants
Low
Antimicrobial therapy for chronic bacterial prostatitis 2013 · Cochrane Headline outcomes only
RR 1.16 [0.86, 1.55]
2 studies · 669 participants
Very low

Adverse effects of treatment ‐ any adverse effects · patients with chronic bacterial prostatitis

Levofloxacin showed no clear difference in adverse effects of treatment ‐ any adverse effects compared with ciprofloxacin (moderate certainty).

1 finding from 1 review

Antimicrobial therapy for chronic bacterial prostatitis 2013 · Cochrane Headline outcomes only
RR 0.86 [0.7, 1.06]
2 studies · 785 participants
Moderate